Compare WST & SSNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | SSNC |
|---|---|---|
| Founded | 1923 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5B | 16.2B |
| IPO Year | 2004 | 2007 |
| Metric | WST | SSNC |
|---|---|---|
| Price | $316.20 | $67.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $325.86 | $96.13 |
| AVG Volume (30 Days) | 843.0K | ★ 2.2M |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | 0.30% | ★ 1.55% |
| EPS Growth | 1.49 | ★ 5.00 |
| EPS | ★ 1.92 | 0.91 |
| Revenue | ★ $2,886,900,000.00 | $1,675,295,000.00 |
| Revenue This Year | $6.76 | $9.20 |
| Revenue Next Year | $6.22 | $4.69 |
| P/E Ratio | $164.33 | ★ $73.43 |
| Revenue Growth | 1.95 | ★ 13.09 |
| 52 Week Low | $206.10 | $64.51 |
| 52 Week High | $330.88 | $91.07 |
| Indicator | WST | SSNC |
|---|---|---|
| Relative Strength Index (RSI) | 64.47 | 44.79 |
| Support Level | $245.28 | $65.15 |
| Resistance Level | $324.52 | $71.98 |
| Average True Range (ATR) | 9.53 | 2.00 |
| MACD | -1.48 | 0.02 |
| Stochastic Oscillator | 58.81 | 36.34 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C acquired robotic process automation software firm Blue Prism.